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OBJECTIVE: To determine the effect of storage duration on cryopreserved ovarian tissue using fresh and frozen-
thawed samples.
METHODS: Seventeen fertile patients underwent an ovarian biopsy during elective laparoscopic tubal ligation. The
tissue sample was divided into three parts: one part was processed fresh (FG), and two were slowly frozen,
cryopreserved for 30 (G30) or 180 days (G180), thawed and analyzed. Follicular density, follicular viability, and
steroidogenic capacity were assessed.
RESULTS: We observed no differences between the groups in follicular density, which was assessed in hematoxylin
and eosin–stained tissue sections. A heterogeneous follicular distribution was observed in the parenchyma, with a
mean density of 361.3¡255.4, 454.9¡676.3, and 296.8¡269.0 follicles/mm3 for FG, G30 and G180, respectively
(p=0.46). Follicular viability was greater in FG (93.4%) when compared with the cryopreserved tissues (70.8% for
G30 (p,0.001) and 78.4% for G180 (p,0.001)), with no difference in viability between the frozen samples (p.0.05).
The steroidogenic capacity of the tissue was not significantly reduced following cryopreservation.
CONCLUSION: The slow freezing procedures used for ovarian cryopreservation are capable of preserving follicular
viability and maintaining the steroidogenic capacity of the tissue despite a roughly 30% decrease in follicular
viability. Furthermore, short-term storage of ovarian tissue does not appear to compromise follicle integrity.
KEYWORDS: Ovarian tissue; Cryopreservation; Tissue damage; Ovarian steroidogenesis; Tissue culture.
Campos JR, Rosa-e-Silva JC, Carvalho BR, Vireque AA, Silva-de-Sa´, MF, Rosa-e-Silva ACJS. Cryopreservation time does not decrease follicular viability in
ovarian tissue frozen for fertility preservation. Clinics. 2011;66(12):2093-2097.
Received for publication on August 8, 2011; First review completed on August 22, 2011; Accepted for publication on September 21, 2011
E-mail: juliocrs@usp.br/jacirarc@gmail.com
Tel.: 55 16 3602-2804
INTRODUCTION
As a result of earlier diagnoses and appropriate treat-
ments, an increasing number of patients are surviving
cancer. However, the cytotoxicity of ionizing radiation and
chemotherapeutic drugs frequently leads to premature
ovarian failure, a condition with serious long-term con-
sequences, including a reduced bone mass that can lead to
osteoporosis, an increased incidence of cardiovascular
disease, and the early occurrence of climacteric symptoms
and infertility. The continuous evolution of assisted repro-
duction techniques has allowed us to develop various
strategies to maintain reproductive function in female
patients treated for neoplastic diseases, including hormonal
manipulation and ovary transposition, as well as cryopre-
servation of embryos, gametes and ovarian cortical tissue.1
The primary objective of freezing of ovarian tissue is the
preservation of ovarian function both in terms of fertility
and hormone production, a goal that has not been attained
using other methods. The freezing of ovarian tissue is
currently used primarily for specific groups of patients for
whom the remaining techniques are not recommended,
such as the following: (1) prepubertal patients in which
ovulation can not be induced for the conservation of
embryos and gametes, (2) women without a partner who
do not desire embryos obtained by fertilization with donor
semen, (3) patients with estrogen-dependent neoplasms,
such as breast cancer, and (4) women with malignant
neoplasms requiring an immediate intervention for whom a
delay in treatment initiation to induce ovulation might
negatively impact the prognosis. In this last situation in
particular, the collection of ovarian cortical tissue for
cryopreservation is advantageous in that it can be per-
formed at any time during the menstrual cycle and allows
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for the acquisition of hundreds of thousands of primordial
follicles.2 Ernst et al.3 reported that one of their patients was
transplanted with six fragments of ovarian tissue after
experiencing a period of menopause and has since
conceived naturally for a second time, giving birth to a
healthy baby girl. This woman is the first reported patient to
have had two children from separate pregnancies as the
result of a transplant of frozen-thawed ovarian tissue. This
result is encouraging and provides support for the devel-
opment of better techniques to cryopreserve ovarian tissue
to maintain the fertility of girls and young women under-
going gonadotoxic treatments. Considerable success has
been achieved in terms of the restoration of patients’
hormonal cyclicity, and to date, 15 healthy children have
been born worldwide as a result of transplanted frozen-
thawed ovarian tissue.4
When considering the reproductive possibilities of
women treated for cancer, it is desirable to wait for a
disease-free interval for a planned pregnancy. As a result,
the ovarian tissue sample must often remain frozen for
variable and possibly long periods of time. This is especially
true for prepubertal female patients. Because the influence
of the storage time on the magnitude of tissue damage has
not been fully explored in cryopreserved ovarian tissue
samples, the objective of the present study was to determine
whether tissue damage progresses during sustained periods
of cryopreservation by assessing the follicular viability and
steroidogenic capacity of fresh ovarian tissue and that of
frozen tissue tissues thawed after 30 and 180 days of
cryopreservation.
MATERIALS AND METHODS
Patients and study design
This was a prospective study conducted on 17 healthy
patients undergoing elective tubal ligation via video
laparoscopy. The mean patient age was 29.0¡2.78 years,
and all patients had at least two healthy living children. The
study was approved by the local Research Ethics
Committee, and all patients provided written informed
consent to participate.
Ovarian tissue biopsies measuring approximately
2.062.0 cm were collected with laparoscopic scissors and
prepared by immersion in nutrient M199 medium (Medium
199, Sigma; sterile filtered and supplemented with Earle’s
salts, L-glutamine and NaHCO3). For sample preparation,
medullary tissue remnants, corpus luteum and eventual
hemorrhagic cysts were eliminated by scraping with a
surgical knife5 so that the tissue would have a maximum
thickness of 2.0 mm with preservation of only the ovarian
cortex for the appropriate penetration of the cryoprotectant
solution. The tissue was then divided into three pieces and
processed as follow: 1) fresh tissue analyzed directly (FG), 2)
ramp frozen and thawed after 30 days (G30), and 3) ramp
frozen and thawed after 180 days (G180).
Each fresh fragment was immediately processed and
evaluated using hematoxylin and eosin (H&E) staining to
quantify the follicular density, LIVE/DEAD staining5 to
measure the follicular viability, and tissue culture with
measurement of steroids in the medium to quantify the
steroidogenic capacity. Tissue culture was performed only
in the last seven cases (Figure 1).
Histological evaluation
The first tissue fragment was fixed in 4% paraformalde-
hyde (Merck, UN 2213 Paraformaldehyd, 4.1, III) and
embedded in paraffin. Serial, 4-mm-thick sections were cut
and stained with H&E. The stained sections were examined
using light microscopy (4006 magnification), and the
number of follicles was counted. For the area calculations,
a macro camera was used that permits the user to choose the
previously captured image, generate its calibration (the
pixel (image unit)6millimeter relationship), and determine
the structural measurements.6 The total number of follicles
per mm3 was calculated using the following formula:
Nt = (No6St6t), where Nt is the number of follicles, No is
the mean number of follicles observed in 1 mm2, St is the
total number of sections in 1 mm3 of tissue, and t is the
section thickness.7
Viability
The second tissue fragment was digested in an enzymatic
solution for 45 minutes containing PBS (Dulbecco’s PBS
with Ca2+ and Mg2+ (16), Invitrogen Gibco) and 1 mg/ml
collagenase (Collagenase Crude Type IA Cell Culture*T,
Sigma) for analysis of follicular viability using a LIVE/DEAD
Viability/Cytotoxicity Kit (Molecular Probes, Invitrogen).
Although this level of structural evaluation was beyond the
scope of the present study, we determined the mean follicular
Figure 1 - Study design.
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viability using a technique that indirectly assesses the
functional capacity of the follicle. The LIVE/DEAD staining
kit exploits the capacity of the cell to metabolize calcein using
calcium as a co-factor. The produced metabolite fluoresces,
and this fluorescence can be detected using microscopy. The
cell must be viable and functional for this fluorescence to
occur. The viability is reported as the percentage of viable
follicles, with follicles considered viable when they contained
a viable oocyte and more than 90% viable granulosa cells.8
In vitro culture
The third tissue fragment was cultured in a-MEM
(Minimum Essential Medium, Invitrogen) supplemented
with 0.1% polyvinylpyrrolidone (PVP-40, Sigma), 100 ng/
ml bovine insulin (Sigma), 10 ng/ml human recombinant
IFG-1 (Invitrogen), 10-7 M androstenedione (Sigma), 11 mM
non-essential amino acids (Gibco), 5 mg/ml human trans-
ferrin (Sigma), 1.4 ng/ml sodium selenite (Acros Organics),
10 mM sodium bicarbonate (Gibco), 0.02 M HEPES (Sigma),
and antibiotics (10,000 IU penicillin and 10,000 IU strepto-
mycin) (Sigma).9 Four fragments (2.0 mm62.0 mm) from
each patient were cultured per ml of medium in 4-well
NUNC plates and incubated in a humidified 5% CO2
atmosphere at 37 C˚ for 144 hours.10 Samples of the culture
samples were taken at 48-hour intervals (0, 48, 96, and
144 hours of culture) and stored at -20 C˚ until the
progesterone (P4) and 17b-estradiol (E2) concentrations
were determined using an ELISA (Siemens).
Cryopreservation of ovarian tissue
The tissue samples were equilibrated in three sequential
freezing solutions containing medium 199 (Medium 199,
Sigma; sterile filtered and supplemented with Earle’s salts,
L-glutamine and NaHCO3), 20% human albumin and 0.5 M
(first step), 1 M (second step), or 1.5 M MS2SO4 (third step
and freezing media), for a duration of 5 minutes each on ice.
Following the last incubation, individual tissue samples
were placed into cryovials containing 1 ml of freezing
media. The tubes were moved to a controlled-rate freezer
(Freeze Control System, CryoLogic, Victoria, Australia) with
the temperature controlled by CryoGenesis V software
(CryoLogic). The samples were cooled at 2 C˚/minute to -
7 C˚, held for 10 minutes at -7 C˚, and when the actual
temperature reached -7 C˚, manual seeding was performed
using a cotton swab saturated with liquid nitrogen. Cooling
was continued at 0.3 C˚/minute until the sample tempera-
ture reached -70 C˚. The tubes were then immersed and
stored in liquid nitrogen (-196 C˚). The two frozen samples
were thawed after 30 and 180 days and analyzed as
described above. We used the rapid thawing method
described by Gosden et al to thaw the samples.11
Statistical analysis
All data were analyzed using GraphPad 5.0 for Windows
(GraphPad Software, San Diego, CA, USA). The mean and
standard deviation of all variables were first calculated, and
the normality was determined using the Kolmogorov-
Smirnov test. The level of significance was set at p,0.05.
The differences in the follicular density, follicular viability
and estradiol and progesterone production in the culture
medium at the different times studied (48, 96, and 144 hours
for the identification of the peak production of these
hormones) between groups were compared using the
Kruskal-Wallis test followed by Dunn’s multiple compar-
ison test.
RESULTS
A heterogeneous follicular distribution in the parench-
yma, with a mean density of 361.3¡255.4, 454.9¡676.3, and
296.8¡269.0 follicles/mm3 for FG, G30, and G180, respec-
tively, was detected following H&E staining (Figure 2).
There were no differences observed between the groups
(p= 0.46).
The follicular viability was higher in FG (93.4%) samples
when compared with the cryopreserved samples (70.8% for
G30 (p,0.001) and 78.4% for G180 (p,0.001)). There was no
difference in the viability of the frozen samples (p.0.05).
The steroid levels in the culture medium at time zero
were undetectable, confirming the absence of hormonal
contamination during the manipulation of the medium. The
average production of E2 and P4 during the seven days of
culture did not decrease significantly after cryopreservation.
There was no observable hormonal peak at the different
culture times (48, 96, and 144 h) among samples of the same
study group. Therefore, to more accurately represent the
levels of these hormones, the mean estradiol (E2) and
progesterone (P4) levels for each study group were
calculated over all of the culture time points. The mean E2
levels were 2026¡1782 pg/ml, 1272¡1081 pg/ml and
849.6¡366.2 pg/ml (p= 0.19) for FG, G30 and G180,
respectively; and the mean P4 levels were 0.45¡0.37 ng/
ml, 0.26¡0.08 ng/ml and 0.45¡0.54 ng/ml (p= 0.86) for
FG, G30, and G180, respectively.
DISCUSSION
In this study, we aimed to determine the quality of
frozen-thawed ovarian tissue after cryopreservation by
assessing different aspects of the recovered tissue, including
follicular density, follicular viability, and steroidogenic
capacity. Follicular density refers to the number of follicles
present in the tissue per unit volume and can vary both with
patient age and within the same patient. Follicular density
has been proposed by several authors as a quality control
criterion to evaulate tissue after thawing.1,12-14 According to
Figure 2 - A histological section of cryopreserved ovarian tissue,
stained with H&E for the assessment of follicular density. The
arrows indicate primordial and primary follicles.
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Poirot et al.2, a mean density of 30 to 400 follicles/mm3
tissue is expected in patients aged 20 to 30 years; however, it
should be noted that follicle distribution is usually not
homogeneous throughout the ovarian cortex. In the present
study, we detected mean follicular densities ranging from
300 to 460 follicles/mm3, in agreement with the literature,
and confirmed the heterogeneous distribution of the
follicles. The objective of the assessment of follicular density
was to guarantee that the various tissue samples would
contain an adequate number of follicles, which would allow
for the evaluation of functional status and viability, as the
fresh and frozen-thawed tissue sections stained with H&E
were obtained from side-by-side fragments.
We also demonstrated the consistency of follicular density
after tissue freezing and thawing, an expected result, as the
loss of follicles due to the process would not have promoted
a significant morphological change. To assess the real
structural integrity of a follicle, it would have been
necessary to examine markers of apoptosis or to perform
an ultra-structural study by electron microscopy, proce-
dures that were not performed as part of this study.
Previous studies examining the effects of cryopreserva-
tion on ovarian tissue have reported a follicular recovery
rate and viability of 40% to 60% when frozen-thawed tissues
were compared with fresh tissue.15,16 In the present study,
slow ramp-freezing was used to preserve human ovarian
biopsies, and this process preserved highly viable immature
oocytes. Obviously, given the careful manipulation of the
recently extracted tissue, the fresh samples were expected to
demonstrate near 100% viability, a finding which was
confirmed in our study.
While various degrees of damage to cryopreserved tissues
have been presented by other authors,5,12,15 a recovery rate
of approximately 60% viable follicles is considered accep-
table5. Indeed, the 30% losses obtained in this study would
be clinically significant compared with the possibility of
using never-frozen tissues; however, in the clinical situa-
tions described (i.e., patients at risk for ovarian failure), the
only options are cryopreservation of the tissue or gametes or
no action at all. Obviously the potential gonadotoxicity of
the chemotherapy to be used and the patients age must be
taken into account. Ovarian tissue cryopreservation techni-
ques should be offered only to patients at a high risk of
ovarian failure; in all other cases, the less the ovary is
manipulated, the better.
In this study, whatever damage occurred in the first 30
days appears unaltered after 180 days, as the percentage of
viable follicles remained the same. We believe that the tissue
damage occurs as a result of surgical manipulation and
tissue processing, which may cause ischemia, and not the
freezing process itself. Previous studies have shown that the
majority of follicle loss occurs during the ischemic period
before implantation and revascularization rather than
during freezing and thawing. In sheep, it was estimated
that approximately 7% of follicles are lost due to the
cryopreservation procedure, whereas 60–70% are lost dur-
ing the revascularization process in conjunction with
transplantation.17 We found no data contesting or support-
ing our results in the literature, indicating that this is the
first report to assess the influence of freezing time on tissue
damage when using tissue cryopreservation techniques.
Based on these findings, we can infer that after the sample is
preserved, storage time should not decrease the quality of
the tissue. Given that the clinical situations in which this
technique is used usually require long periods of conserva-
tion, this information is extremely valuable for the manage-
ment of these cases. Several authors have reported the
implantation or use of samples preserved for different
periods of time with promising results.18
In the same way that structural integrity does not reflect
tissue viability, it also does not guarantee tissue function-
ality. We therefore assessed the steroidogenic capacity of the
tissue, which in turn allowed us to infer the quality of its
function in terms of hormone production. Ovarian tissue
culture has been described by some authors as a way of
assessing the functional capacity of ovarian tissue or of
obtaining follicles in more advanced developmental stages
for reproductive purposes.19,20 Sadeu et al.21 reported
maintaining the viability of and inducing partial follicle
maturation in human fetal ovarian cultures for up to 63
days. Thus, in light of the proven capacity for tissue survival
in culture medium, we chose this model for functional
evaluation of the cryopreserved tissue. It should be noted
that one of the premises underlying the cryopreservation of
ovarian tissue rather than isolated gametes is the possibility
of maintaining the steroidogenic capacity of the tissue and
not simply retaining the reproductive capacity.
In this study, the levels of estradiol and progesterone
released by the ovarian tissue into the culture medium
indicated that the steroidogenic capacity of the tissue was
preserved. In addition, the cultured tissue continued to
produce equivalent hormone quantities throughout the
duration of culture and maintained the same rates of
hormone production, indicating good tissue conservation
during culture. It must be noted that the size of the cultured
samples was standardized so that the tissue volume would
not influence the hormone concentrations in the medium
and thus generate a methodological bias.
In addition, hormone production did not differ between
cultures of tissue frozen for 30 or 180 days, demonstrating
that the capacity to produce hormones was preserved after
cryopreservation, regardless of storage time. This result
emphasizes the lack of further tissue damage due to the
maintenance of low temperatures and supports the folli-
cular viability findings, namely that the tissue damage is
more likely due to the manipulation and processing of the
sample than to the freezing process.
Finally, steroidogenic function does not necessarily
indicate that reproductive function is maintained, as the
ovary naturally first loses its reproductive capacity and then
its steroidogenic capacity. This is best illustrated by normal
ovarian physiology: fecundity abruptly decreases after 40
years of age (e.g., pregnancy rates of less than 5% after 40
years), whereas menopause occurs, on average, between 50
and 55 years of age.
Although ovarian tissue cryopreservation is still consid-
ered an experimental technique,1 many assisted reproduc-
tion centers have been routinely performing this procedure
despite the lack of consensus statements concerning the
selection of appropriate candidates22 or formal support
from the relevant professional societies (e.g., the American
Society of Oncology and the American Society for
Reproductive Medicine) for its large-scale application.1
However, if the risk of ovarian failure related to oncologic
treatment is high, then we believe that the patient should
have autonomy in deciding whether or not to undergo the
procedure after receiving in-depth information about the
risks, benefits and effectiveness of the technique.
Cryopreservation and ovarian function
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Many questions have arisen regarding ovarian tissue
cryopreservation, such as the determination of the best
candidates for this procedure, the best methods for tissue
removal, the best form of freezing and thawing, whether
one or both ovaries should be cryopreserved in full or in
fragments, what the best site for re-implantation would be
and whether vascular anastomosis should be performed.
Further clinical and experimental studies are needed in
order to address these concerns.
Despite the aforementioned points, we consider the
technique to be adequate regarding the conservation of
tissue and the maintenance of tissue viability and functional
capacity, although the reproductive aspects of this proce-
dure have yet to be explored. Nonetheless, there are
enormous ethical implications involved in this type of
evaluation. Only embryo fertilization, implantation and the
birth of a healthy baby would confirm preservation of
ovarian function and reproductive capacity.
Based on our findings, we conclude that although some
loss in viability is observed after cryopreservation, the
duration of cryopreservation does not interfere with the
morphology or steroidogenic capacity of ovarian tissue.
These findings permit the implementation of a safe and
reliable standardized technique for human ovarian tissue
freezing. It should be noted that the primary limitation
regarding cryopreservation is currently the limited use of this
tissue after thawing, with the published results still limited to
case reports and studies examining small series of patients.
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